CD4 and lung carcinoma: The proportion of CD4+/CD3+/CD25+/FoxP3+ CD4+ Treg cells and CD8+/CD3+/CD25+/FoxP3+ regulatory CD8+ Treg cells were significantly elevated in all the lung cancer patients before surgery, but not in the RFC group after surgery (Figure 6d).